Talis Biomedical Corp Financials

Talis Biomedical Stock Summary

Talis Biomedical competes with Tivic Health, Bluejay Diagnostics, Heart Test, Nuwellis, and Bone Biologics. Talis Biomedical Corporation operates as a molecular diagnostic company. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California. Talis Biomedical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 242 people.

Talis Biomedical Key Financial Ratios

There are many critical financial ratios that Talis Biomedical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Talis Biomedical Corp reports annually and quarterly.

Talis Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Talis Biomedical's current stock value. Our valuation model uses many indicators to compare Talis Biomedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Talis Biomedical competition to find correlations between indicators driving Talis Biomedical's intrinsic value. More Info.Talis Biomedical Corp is rated fourth in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Talis Biomedical's earnings, one of the primary drivers of an investment's value.

Talis Biomedical Market Pulse

Along with financial statement analysis, the daily predictive indicators of Talis Biomedical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Talis Biomedical Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Talis Biomedical Corp based on widely used predictive technical indicators. In general, we focus on analyzing Talis Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Talis Biomedical's daily price indicators and compare them against related drivers.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

If you are still planning to invest in Talis Biomedical Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talis Biomedical's history and understand the potential risks before investing.